These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23616213)

  • 1. Domain organization of membrane-bound factor VIII.
    Stoilova-McPhie S; Lynch GC; Ludtke S; Pettitt BM
    Biopolymers; 2013 Jul; 99(7):448-59. PubMed ID: 23616213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimeric Organization of Blood Coagulation Factor VIII bound to Lipid Nanotubes.
    Dalm D; Galaz-Montoya JG; Miller JL; Grushin K; Villalobos A; Koyfman AY; Schmid MF; Stoilova-McPhie S
    Sci Rep; 2015 Jun; 5():11212. PubMed ID: 26082135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helical organization of blood coagulation factor VIII on lipid nanotubes.
    Miller J; Dalm D; Koyfman AY; Grushin K; Stoilova-McPhie S
    J Vis Exp; 2014 Jun; (88):. PubMed ID: 24961276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of recombinant factor VIII B-domain induces phospholipid vesicle aggregation: implications for the immunogenicity of factor VIII.
    Grushin K; Miller J; Dalm D; Parker ET; Healey JF; Lollar P; Stoilova-McPhie S
    Haemophilia; 2014 Sep; 20(5):723-31. PubMed ID: 24750465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-Dimensional structure of membrane-bound coagulation factor VIII: modeling of the factor VIII heterodimer within a 3-dimensional density map derived by electron crystallography.
    Stoilova-McPhie S; Villoutreix BO; Mertens K; Kemball-Cook G; Holzenburg A
    Blood; 2002 Feb; 99(4):1215-23. PubMed ID: 11830468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryo-electron microscopy of coagulation Factor VIII bound to lipid nanotubes.
    Parmenter CD; Cane MC; Zhang R; Stoilova-McPhie S
    Biochem Biophys Res Commun; 2008 Feb; 366(2):288-93. PubMed ID: 18039465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replacing the factor VIII C1 domain with a second C2 domain reduces factor VIII stability and affinity for factor IXa.
    Wakabayashi H; Fay PJ
    J Biol Chem; 2013 Oct; 288(43):31289-97. PubMed ID: 24030831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor VIII organisation on nanodiscs with different lipid composition.
    Grushin K; Miller J; Dalm D; Stoilova-McPhie S
    Thromb Haemost; 2015 Apr; 113(4):741-9. PubMed ID: 25589466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for inhibition of coagulation factor VIII reveals a shared antigenic hotspot on the C1 domain.
    Childers KC; Cowper B; Vaughan JD; McGill JR; Davulcu O; Lollar P; Doering CB; Coxon CH; Spiegel PC
    J Thromb Haemost; 2024 Sep; 22(9):2449-2459. PubMed ID: 38849084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of Factor VIII to Lipid Nanodiscs Increases its Clotting Function in a Mouse Model of Hemophilia A.
    Csencsits-Smith K; Grushin K; Stoilova-McPhie S
    J Blood Disord Transfus; 2015 Dec; 6(6):325. PubMed ID: 28936365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and functional characterization of platelet receptor-mediated factor VIII binding.
    Ahmad SS; Scandura JM; Walsh PN
    J Biol Chem; 2000 Apr; 275(17):13071-81. PubMed ID: 10777612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trp2313-His2315 of factor VIII C2 domain is involved in membrane binding: structure of a complex between the C2 domain and an inhibitor of membrane binding.
    Liu Z; Lin L; Yuan C; Nicolaes GA; Chen L; Meehan EJ; Furie B; Furie B; Huang M
    J Biol Chem; 2010 Mar; 285(12):8824-9. PubMed ID: 20089867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor VIII A3 domain residues 1793-1795 represent a factor IXa-interactive site in the tenase complex.
    Takeyama M; Furukawa S; Sasai K; Horiuchi K; Nogami K
    Biochim Biophys Acta Gen Subj; 2023 Aug; 1867(8):130381. PubMed ID: 37207906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A3 domain region 1803-1818 contributes to the stability of activated factor VIII and includes a binding site for activated factor IX.
    Bloem E; Meems H; van den Biggelaar M; Mertens K; Meijer AB
    J Biol Chem; 2013 Sep; 288(36):26105-26111. PubMed ID: 23884417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor VIII mutated with Lys1813Ala within the factor IXa-binding region enhances intrinsic coagulation potential.
    Nakajima Y; Takeyama M; Oda A; Shimonishi N; Nogami K
    Blood Adv; 2023 Apr; 7(8):1436-1445. PubMed ID: 36322904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of factor VIII by factor IXa.
    O'Brien DP; Johnson D; Byfield P; Tuddenham EG
    Biochemistry; 1992 Mar; 31(10):2805-12. PubMed ID: 1547220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor VIII lacking the C2 domain retains cofactor activity in vitro.
    Wakabayashi H; Griffiths AE; Fay PJ
    J Biol Chem; 2010 Aug; 285(33):25176-84. PubMed ID: 20529839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrogen-Deuterium Exchange Mass Spectrometry Identifies Activated Factor IX-Induced molecular Changes in Activated Factor VIII.
    van Galen J; Freato N; Przeradzka MA; Ebberink EHTM; Boon-Spijker M; van der Zwaan C; van den Biggelaar M; Meijer AB
    Thromb Haemost; 2021 May; 121(5):594-602. PubMed ID: 33302303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interface between the EGF2 domain and the protease domain in blood coagulation factor IX contributes to factor VIII binding and factor X activation.
    Fribourg C; Meijer AB; Mertens K
    Biochemistry; 2006 Sep; 45(35):10777-85. PubMed ID: 16939230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some human inhibitor antibodies interfere with factor VIII binding to factor IX.
    Zhong D; Saenko EL; Shima M; Felch M; Scandella D
    Blood; 1998 Jul; 92(1):136-42. PubMed ID: 9639509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.